Programmes and partnerships

We have the medicine to treat serious chronic diseases, like diabetes and rare blood diseases, successfully. But the reality is that in low- and middle-income, many people struggle to afford, or get access to, the care they need. There are a multitude of reasons for this. Medicine is too costly, or the pharmacy or hospital where it is available is too far away. In some communities, there is a critical shortage of trained doctors and nurses, not to mention medical equipment.

Collaboration is the key to helping more people

Placeholder

Collaboration is the key to helping more people

The challenges are significant, but solving them is not impossible. It takes cooperation and the knowledge and skills from many different organisations. 

For more than two decades, we have been working in partnerships and co-creating programmes with local governments, companies, universities, public organisations and humanitarian organisations. We learn from each other as we tackle access and affordability issue together.

We share a common goal – helping people get the chronic disease care they need, no matter where they live. 

Keep reading and discover our access to care programmes and partnerships in low- and middle-income countries.

We provide a future for children with type 1 diabetes

Ranjith had type 1 diabetes and is enrolled in the Changing Diabetes® in Children programme in India.

We provide a future for children with type 1 diabetes

It is an unbearable truth. But in many of the world’s poorest countries, life expectancy for children with type 1 diabetes is very short. Because often, insulin is not available or accessible. 

These children deserve a better future. 

The Changing Diabetes®  in Children programme has brought us together with Roche, the International Society for Pediatric and Adolescent Diabetes and the World Diabetes Foundation to ensure care and life-saving insulin for children in countries where they need it the most. 

The programme takes a holistic approach, because we know that it takes more than medicine to create a better tomorrow.

Today, Changing Diabetes® in Children is providing medical care and insulin to more than 26,000 children. By 2030, we aim to reach 100,000.

Learn more about Changing Diabetes® in Children.

Improving diabetes care in humanitarian crises  

Worldwide, 500 million people live in fragile and conflict-affected situations. Many of these people require access to care for non-communicable diseases, including diabetes and hypertension.

COVID-19 emergency donation to humanitarian organisations.

Partnering for Change

We work closely with the International Committee of the Red Cross and the Danish Red Cross in order to tackle this issue and solve the growing need for chronic disease treatment. 

The Partnering For Change partnership allows us to move quickly in times of crisis. From assessing and reducing risk factors, to providing care to people in need and raising awareness.

During the COVID-19 crisis, our humanitarian efforts have included providing free insulin and shipment to our Red Cross partners and other humanitarian organisations until October 2020.

Learn more about our partnership with the Red Cross.

Together, we aim to defeat chronic diseases

Faruqul Islam Mozumder with his daugther. Faruqul has type 2 diabetes and lives in Bangladesh.

Together, we aim to defeat chronic diseases

Chronic or non-communicable diseases (NCD) like type 2 diabetes are the leading cause of death and disability globally. 

Many of the world’s poorest countries are the hardest hit. In fact, a person living in a low-income country faces a lifetime chance of 20-30% of dying from an NCD under the age of 70. This is two to four times higher than in a high-income country.

To enable and assist lower-income and lesser developed countries to scale-up sustained action against NCDs, we joined the Defeat-NCD Partnership. 

The public–private–people partnership aims to gather and mobilise global and national knowledge, tools, capacities and finances. Thereby, reducing premature deaths from NCDs.

Learn more about the Defeat-NCD Partnership.

Innovative solutions to keep insulin and care affordable

For the working poor in low- and middle-income countries, living with diabetes and paying for insulin treatment is a daily struggle.

Base of the Pyramid programme

As the world’s largest producer of human insulin, it is both a responsibility and a business opportunity to support local health authorities in making sure that insulin reaches these people – at a price they can afford.

To fight against price increases in the medicine supply chain, we have introduced the Base of the Pyramid programme. The programme aims to improve access to medicine and ease the cost burden of diabetes care. 

Learn more about the Base of the Pyramid programme (pdf).